• Kyodo


The government is expected to reach a deal soon with British drugmaker AstraZeneca PLC to secure over 100 million doses of a novel coronavirus vaccine being developed with the University of Oxford, a source close to the matter said Friday.

The drugmaker has announced that it will start supplying its COVID-19 vaccine overseas in September, and is expected to begin clinical trials in Japan later this month to confirm its efficacy and safety.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.